Technical Analysis for ARVN - Arvinas, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 63.0 | 0.17% | 0.11 |
ARVN closed up 0.17 percent on Thursday, April 15, 2021, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Apr 26
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical ARVN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 0.17% | |
| Multiple of Ten Bullish | Other | 2.71% | |
| Multiple of Ten Bullish | Other | 4.22% | |
| Wide Bands | Range Expansion | -0.77% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 14 hours ago |
| Down 1% | about 14 hours ago |
| 20 DMA Resistance | about 17 hours ago |
| 10 DMA Resistance | about 17 hours ago |
| Rose Above 20 DMA | about 17 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/26/2021
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Genetics Proprietary Technology Metabolism Androgen Receptor Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Genetics Proprietary Technology Metabolism Androgen Receptor Chimera
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 92.77 |
| 52 Week Low | 19.68 |
| Average Volume | 410,827 |
| 200-Day Moving Average | 46.99 |
| 50-Day Moving Average | 71.71 |
| 20-Day Moving Average | 63.60 |
| 10-Day Moving Average | 63.71 |
| Average True Range | 4.13 |
| ADX | 23.15 |
| +DI | 18.10 |
| -DI | 21.89 |
| Chandelier Exit (Long, 3 ATRs ) | 66.88 |
| Chandelier Exit (Short, 3 ATRs ) | 68.98 |
| Upper Bollinger Band | 68.43 |
| Lower Bollinger Band | 58.77 |
| Percent B (%b) | 0.44 |
| BandWidth | 15.19 |
| MACD Line | -2.46 |
| MACD Signal Line | -2.72 |
| MACD Histogram | 0.2692 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 66.70 | ||||
| Resistance 3 (R3) | 66.85 | 65.76 | 66.08 | ||
| Resistance 2 (R2) | 65.76 | 64.82 | 65.69 | 65.88 | |
| Resistance 1 (R1) | 64.38 | 64.24 | 63.84 | 64.23 | 65.67 |
| Pivot Point | 63.30 | 63.30 | 63.03 | 63.22 | 63.30 |
| Support 1 (S1) | 61.92 | 62.36 | 61.38 | 61.77 | 60.33 |
| Support 2 (S2) | 60.83 | 61.77 | 60.76 | 60.12 | |
| Support 3 (S3) | 59.45 | 60.83 | 59.92 | ||
| Support 4 (S4) | 59.30 |
